|
|
||||||||
1 From the Department of Molecular Biology and Applied Physiology, 2 Department of Ophthalmology, and 3 Second Department of Internal Medicine, Tohoku University School of Medicine, Miyagi, Japan.
PURPOSE. To determine whether adrenomedullin (ADM), a vasorelaxant peptide is produced and secreted by human retinal pigment epithelial (RPE) cells, whether ADM expression is regulated by inflammatory cytokines and a growth factor, and whether ADM has proliferative effects on these cells.
METHODS. Production and secretion of ADM by cultured human RPE cells were
examined by Northern blot analysis and radioimmunoassay. Regulation of
the ADM expression by basic fibroblast growth factor, interferon
(IFN)-
, tumor necrosis factor-
, interleukin (IL)-1ß, or
all-trans-retinoic acid was studied. In addition, proliferative
effects of ADM on human RPE cells were examined by modified
3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay.
RESULTS. ADM mRNA was expressed constitutively in all three human RPE cell lines
(F-0202, D407, and ARPE-19) examined. Immunoreactive ADM was detected
in the cultured media by radioimmunoassay. Sephadex G-50 column
chromatography of the cultured medium showed a single peak eluting in
the position of ADM-(1-52). Treatment with IFN-
or IL-1ß increased
ADM mRNA levels and immunoreactive-ADM levels in the medium in dose-
and time-dependent manners in ARPE-19 cells. Exogenously added ADM
increased the number of F-0202 cells and ARPE-19 cells, and the
treatment with ADM antibody or ADM-(22-52) (an ADM antagonist)
decreased it.
CONCLUSIONS. Human RPE cells produced and secreted ADM. IFN-
and IL-1ß induced
ADM expression in ARPE-19 cells. Furthermore, ADM stimulated
proliferation of RPE cells. These results raise the possibility that
ADM is related to the pathophysiology of some inflammatory and
proliferative ocular diseases.
This article has been cited by other articles:
![]() |
R. T. Dackor, K. Fritz-Six, W. P. Dunworth, C. L. Gibbons, O. Smithies, and K. M. Caron Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol. Cell. Biol., April 1, 2006; 26(7): 2511 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. S. Rao, V. Palamalai, J. R. Dunlevy, and M. Miyagi Peptidyl-Lys Metalloendopeptidase-catalyzed 18O Labeling for Comparative Proteomics: Application to Cytokine/Lipolysaccharide-treated Human Retinal Pigment Epithelium Cell Line Mol. Cell. Proteomics, October 1, 2005; 4(10): 1550 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, L. Wang, M. Yuan, J. Ma, and Y. Hui Adrenomedullin Affects Two Signal Transduction Pathways and the Migration in Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1507 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boussery, C. Delaey, and J. Van de Voorde Influence of Adrenomedullin on Tone of Isolated Bovine Retinal Arteries Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Dorner, G. Garhofer, K.-H. Huemer, E. Golestani, C. Zawinka, L. Schmetterer, and M. Wolzt Effects of Adrenomedullin on Ocular Hemodynamic Parameters in the Choroid and the Ophthalmic Artery Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3947 - 3951. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Hofbauer, E. Schoof, A. Kurtz, and P. Sandner Inflammatory Cytokines Stimulate Adrenomedullin Expression Through Nitric Oxide-Dependent and -Independent Pathways Hypertension, January 1, 2002; 39(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Udono, K. Takahashi, M. Nakayama, A. Yoshinoya, K. Totsune, O. Murakami, Y. K. Durlu, M. Tamai, and S. Shibahara Induction of Adrenomedullin by Hypoxia in Cultured Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1080 - 1086. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |